ODI Pharma AB (publ) (FRA:6OD)
Germany flag Germany · Delayed Price · Currency is EUR
0.3260
-0.0080 (-2.40%)
Last updated: Jan 28, 2026, 8:15 AM CET

ODI Pharma AB Balance Sheet

Millions SEK. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
2.891.482.646.497.3614.62
Cash & Short-Term Investments
2.891.482.646.497.3614.62
Cash Growth
-42.14%-43.87%-59.28%-11.76%-49.69%-28.71%
Accounts Receivable
3.260.128.070.130.11-
Other Receivables
1.051.380.910.680.990.93
Receivables
4.311.498.980.811.090.93
Inventory
---0.811.431.05
Prepaid Expenses
0.190.630.590.06--
Other Current Assets
---00.60.26
Total Current Assets
7.393.6112.228.1810.4816.87
Property, Plant & Equipment
000.010.010.010.01
Other Long-Term Assets
-10---
Total Assets
7.394.6112.238.1910.516.88
Accounts Payable
3.990.3950.710.670.15
Accrued Expenses
0.321.011.160.35--
Current Income Taxes Payable
000.090--
Current Unearned Revenue
----0.550.4
Other Current Liabilities
2.792.793.984.540.010.04
Total Current Liabilities
7.14.1910.235.611.240.58
Total Liabilities
7.14.1910.235.611.240.58
Common Stock
0.730.640.610.610.610.61
Additional Paid-In Capital
27.0825.9621.8421.8421.8421.84
Comprehensive Income & Other
-27.52-26.17-20.45-19.88-13.19-6.15
Shareholders' Equity
0.290.4222.579.2616.3
Total Liabilities & Equity
7.394.6112.238.1910.516.88
Net Cash (Debt)
2.891.482.646.497.3614.62
Net Cash Growth
-42.14%-43.87%-59.28%-11.76%-49.69%-28.71%
Net Cash Per Share
0.150.080.170.420.490.95
Filing Date Shares Outstanding
18.3318.3315.2215.2215.2215.22
Total Common Shares Outstanding
18.3318.3315.2215.2215.2215.22
Working Capital
0.29-0.581.992.569.2516.29
Book Value Per Share
0.020.020.130.170.611.07
Tangible Book Value
0.290.4222.579.2616.3
Tangible Book Value Per Share
0.020.020.130.170.611.07
Machinery
-0.040.040.040.040.03
Source: S&P Global Market Intelligence. Standard template. Financial Sources.